LGND — Ligand Pharmaceuticals Incorporated

LGNDLigand Pharmaceuticals Incorporated

NAS · US · Healthcare · Biotechnology · ligand.com

235.00USD+2.47%Mkt Cap: 4.71B USDP/E: 30.69Last update: 2026-05-26

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap4.71B USD

Enterprise Value4.13B USD

Revenue (TTM)274.48M USD

Gross Profit253.54M USD

Net Income (TTM)124.45M USD

Revenue/Share14.07 USD

Last Price235.00 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees47

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS53220K5048

Valuation

P/E (Trailing)30.69

P/E (Forward)19.57

PEG1.53

EV/EBITDA30.68

EV/Revenue15.03

P/S16.22

P/B4.46

EPS (TTM)7.67

EPS (Forward)11.36

52W Range

98.8992% of range247.38

52W High247.38 USD

52W Low98.89 USD

Profitability

Gross Margin94.57%

Oper. Margin33.58%

EBITDA Margin48.98%

Profit Margin46.42%

ROE12.23%

ROA7.97%

Growth

Revenue Growth14.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF49.36M USD

CapEx (TTM)11.31M USD

FCF Margin51.77%

FCF Yield3.02%

Net Debt-327.43M USD

Net Debt/EBITDA-2.44

Balance Sheet

Debt/Equity0.44

Current Ratio21.28

Quick Ratio20.81

Book Value/Sh49.79 USD

Cash/Share38.89 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateJul 2, 2010

Pay Date—

Splits

Last Split1603:1000

Split DateNov 2, 2022

Analyst Consensus

Rating1.2 (Strong Buy)

Target (Mean)271.80 USD

Target Range220.00 USD – 330.00 USD

# Analysts10

Ownership

Shares Out.20.04M

Float19.57M

Insiders2.39%

Institutions106.46%

Short Interest

Short Ratio6.5d

Short % Float8.70%

Short % Out.7.26%

Shares Short1.46M

Short (prev mo.)1.50M

Technical

SMA 50215.72 (+8.9%)

SMA 200192.99 (+21.8%)

Beta1.07

S&P 52W Chg28.31%

Avg Vol (30d)223.55K

Avg Vol (10d)187.14K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—